We and others have indicated that FtMt-deficient mice do not show any evident phenotypes or iron-related disorders under baseline feeding conditions but that FtMt exerts significant protective effects under pathological conditions, such as in Alzheimer’s disease and Parkinson’s disease28–31. This evidence concerns the gene FTMT and early-onset autosomal dominant Alzheimer disease.